What one share of GSK holds
GSK is a global biopharma group which prevents and treats disease with specialty medicines, vaccines and general medicines. GSK focuses on the science of the immune system and advanced technologies, investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology;
GSK’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.
| Sales | $20.93 |
|---|---|
| Profit | $3.66 |
| Capex (buildings and equipment) | $0.86 |
| Free cash flow | $4.10 |
| Dividends | $1.74 |
| Cash and investments | $2.12 |
| Debt | $9.01 |
| Book value | $10.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2015 | $14.96 | $5.27 | $0.86 | $0.74 | $2.45 | $5.42 |
| 2016 | $15.40 | $0.50 | $0.85 | $2.74 | $2.17 | $0.57 |
| 2017 | $15.75 | $0.80 | $0.81 | $2.80 | — | −$0.03 |
| 2018 | $16.57 | $1.95 | $0.72 | $3.80 | $213.80 | $1.79 |
| 2019 | $17.18 | $2.36 | $0.64 | $3.44 | $204.29 | $5.62 |
| 2020 | $15.51 | $3.66 | $0.63 | $4.74 | $2.57 | $7.40 |
| 2021 | $16.78 | $2.98 | $0.65 | $4.76 | $2.75 | $7.55 |
| 2022 | $17.77 | $9.06 | $0.69 | $3.79 | $1.52 | $5.94 |
| 2023 | $18.35 | $2.98 | $0.80 | $3.30 | $1.44 | $7.89 |
| 2024 | $19.36 | $1.59 | $0.86 | $3.18 | $1.56 | $7.93 |
| 2025 | $20.93 | $3.66 | $0.86 | $4.10 | $1.74 | $10.21 |
Common questions about GSK
How much does one share of GSK earn?
Over its latest fiscal year, each share of GSK earned $3.66 of profit on $20.93 of sales, keeping about 17¢ of every $1 (profit margin).
Does GSK pay a dividend?
Yes. GSK paid $1.74 per share in dividends over its latest fiscal year. That’s about 48¢ of each $1 of profit (payout ratio).
What is GSK’s book value per share?
GSK’s book value is $10.21 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.
How much cash and debt does each share of GSK have?
Each share of GSK has $2.12 of cash and investments and $9.01 of debt, as of December 31, 2025.
What is GSK’s free cash flow per share?
$4.10 per share over its latest fiscal year. Free cash flow is the cash left over after spending on buildings and equipment.
How has GSK’s profit per share changed over time?
Profit per share went from $5.27 in 2015 to $3.66 in 2025, shrinking about 3.6% a year (adjusted for stock splits).
Has GSK bought back shares?
GSK’s share count fell about 16% from 2015 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.